Annual Current Liabilities
$164.10 M
+$8.20 M+5.26%
December 1, 2024
Summary
- As of March 13, 2025, MYGN annual total current liabilities is $164.10 million, with the most recent change of +$8.20 million (+5.26%) on December 1, 2024.
- During the last 3 years, MYGN annual current liabilities has fallen by -$40.20 million (-19.68%).
- MYGN annual current liabilities is now -24.55% below its all-time high of $217.50 million, reached on June 30, 2017.
Performance
MYGN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$164.10 M
+$9.80 M+6.35%
December 1, 2024
Summary
- As of March 13, 2025, MYGN quarterly total current liabilities is $164.10 million, with the most recent change of +$9.80 million (+6.35%) on December 1, 2024.
- Over the past year, MYGN quarterly current liabilities has increased by +$8.20 million (+5.26%).
- MYGN quarterly current liabilities is now -40.31% below its all-time high of $274.90 million, reached on September 30, 2016.
Performance
MYGN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MYGN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.3% | +5.3% |
| 3 y3 years | -19.7% | +5.3% |
| 5 y5 years | +11.6% | +5.3% |
MYGN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.7% | +19.6% | -25.8% | +37.1% |
| 5 y | 5-year | -19.7% | +39.3% | -39.5% | +46.0% |
| alltime | all time | -24.6% | +2996.2% | -40.3% | +3391.5% |
Myriad Genetics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $164.10 M(+5.3%) | $164.10 M(+6.4%) |
| Sep 2024 | - | $154.30 M(+3.6%) |
| Jun 2024 | - | $148.90 M(+1.9%) |
| Mar 2024 | - | $146.10 M(-6.3%) |
| Dec 2023 | $155.90 M(+13.6%) | $155.90 M(-25.5%) |
| Sep 2023 | - | $209.30 M(-5.3%) |
| Jun 2023 | - | $221.10 M(+54.3%) |
| Mar 2023 | - | $143.30 M(+4.4%) |
| Dec 2022 | $137.20 M(-32.8%) | $137.20 M(+6.3%) |
| Sep 2022 | - | $129.10 M(+7.9%) |
| Jun 2022 | - | $119.70 M(-27.9%) |
| Mar 2022 | - | $166.00 M(-18.7%) |
| Dec 2021 | $204.30 M(+40.0%) | $204.30 M(+0.5%) |
| Sep 2021 | - | $203.20 M(-25.0%) |
| Jun 2021 | - | $271.00 M(+81.9%) |
| Mar 2021 | - | $149.00 M(+11.4%) |
| Dec 2020 | $145.90 M(-0.7%) | - |
| Sep 2020 | - | $133.70 M(-9.0%) |
| Jun 2020 | $147.00 M(+24.8%) | $147.00 M(+29.9%) |
| Mar 2020 | - | $113.20 M(+0.7%) |
| Dec 2019 | - | $112.40 M(-2.6%) |
| Sep 2019 | - | $115.40 M(-2.0%) |
| Jun 2019 | $117.80 M(+15.3%) | $117.80 M(+8.2%) |
| Mar 2019 | - | $108.90 M(-3.9%) |
| Dec 2018 | - | $113.30 M(+4.9%) |
| Sep 2018 | - | $108.00 M(+5.7%) |
| Jun 2018 | $102.20 M(-53.0%) | $102.20 M(+8.4%) |
| Mar 2018 | - | $94.30 M(-40.8%) |
| Dec 2017 | - | $159.30 M(+14.4%) |
| Sep 2017 | - | $139.20 M(-36.0%) |
| Jun 2017 | $217.50 M(+200.8%) | $217.50 M(-1.9%) |
| Mar 2017 | - | $221.70 M(+167.8%) |
| Dec 2016 | - | $82.80 M(-69.9%) |
| Sep 2016 | - | $274.90 M(+280.2%) |
| Jun 2016 | $72.30 M(+5.2%) | $72.30 M(+9.4%) |
| Mar 2016 | - | $66.10 M(+0.3%) |
| Dec 2015 | - | $65.90 M(+11.7%) |
| Sep 2015 | - | $59.00 M(-14.1%) |
| Jun 2015 | $68.70 M(-14.8%) | $68.70 M(+2.3%) |
| Mar 2015 | - | $67.17 M(+12.3%) |
| Dec 2014 | - | $59.84 M(-11.6%) |
| Sep 2014 | - | $67.72 M(-16.0%) |
| Jun 2014 | $80.60 M(+24.9%) | $80.60 M(+11.7%) |
| Mar 2014 | - | $72.16 M(+7.1%) |
| Dec 2013 | - | $67.39 M(-14.7%) |
| Sep 2013 | - | $79.03 M(+22.5%) |
| Jun 2013 | $64.51 M(+43.5%) | $64.51 M(+20.3%) |
| Mar 2013 | - | $53.62 M(+17.9%) |
| Dec 2012 | - | $45.49 M(-20.7%) |
| Sep 2012 | - | $57.36 M(+27.6%) |
| Jun 2012 | $44.97 M(+30.8%) | $44.97 M(+21.4%) |
| Mar 2012 | - | $37.05 M(+5.7%) |
| Dec 2011 | - | $35.05 M(+12.0%) |
| Sep 2011 | - | $31.29 M(-9.0%) |
| Jun 2011 | $34.39 M(+25.2%) | $34.39 M(+47.1%) |
| Mar 2011 | - | $23.37 M(+0.8%) |
| Dec 2010 | - | $23.19 M(-25.0%) |
| Sep 2010 | - | $30.93 M(+12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | $27.47 M(-14.6%) | $27.47 M(+23.6%) |
| Mar 2010 | - | $22.22 M(-2.2%) |
| Dec 2009 | - | $22.71 M(+8.2%) |
| Sep 2009 | - | $20.99 M(-34.7%) |
| Jun 2009 | $32.17 M(-56.3%) | $32.17 M(-11.9%) |
| Mar 2009 | - | $36.50 M(-32.2%) |
| Dec 2008 | - | $53.82 M(-0.7%) |
| Sep 2008 | - | $54.18 M(-26.5%) |
| Jun 2008 | $73.69 M(+109.5%) | $73.69 M(+95.7%) |
| Mar 2008 | - | $37.66 M(+7.9%) |
| Dec 2007 | - | $34.89 M(+10.3%) |
| Sep 2007 | - | $31.62 M(-10.1%) |
| Jun 2007 | $35.18 M(+31.1%) | $35.18 M(+53.2%) |
| Mar 2007 | - | $22.96 M(-13.3%) |
| Dec 2006 | - | $26.47 M(+15.4%) |
| Sep 2006 | - | $22.95 M(-14.4%) |
| Jun 2006 | $26.82 M(+15.2%) | $26.82 M(+24.2%) |
| Mar 2006 | - | $21.59 M(-8.4%) |
| Dec 2005 | - | $23.58 M(+5.5%) |
| Sep 2005 | - | $22.35 M(-4.0%) |
| Jun 2005 | $23.29 M(+54.4%) | $23.29 M(+40.8%) |
| Mar 2005 | - | $16.54 M(-4.7%) |
| Dec 2004 | - | $17.36 M(+25.2%) |
| Sep 2004 | - | $13.86 M(-8.1%) |
| Jun 2004 | $15.08 M(-22.0%) | $15.08 M(+1.6%) |
| Mar 2004 | - | $14.84 M(+15.1%) |
| Dec 2003 | - | $12.89 M(+5.6%) |
| Sep 2003 | - | $12.21 M(-36.9%) |
| Jun 2003 | $19.34 M(-32.2%) | $19.34 M(+49.7%) |
| Mar 2003 | - | $12.92 M(-40.4%) |
| Dec 2002 | - | $21.67 M(+34.7%) |
| Sep 2002 | - | $16.09 M(-43.6%) |
| Jun 2002 | $28.52 M(-12.5%) | $28.52 M(+50.7%) |
| Mar 2002 | - | $18.93 M(-7.0%) |
| Dec 2001 | - | $20.36 M(-7.3%) |
| Sep 2001 | - | $21.97 M(-32.6%) |
| Jun 2001 | $32.58 M(+13.7%) | $32.58 M(+41.6%) |
| Mar 2001 | - | $23.01 M(+6.0%) |
| Dec 2000 | - | $21.70 M(-9.7%) |
| Sep 2000 | - | $24.03 M(-16.2%) |
| Jun 2000 | $28.67 M(+440.9%) | $28.67 M(+26.8%) |
| Mar 2000 | - | $22.62 M(+22.9%) |
| Dec 1999 | - | $18.40 M(+27.8%) |
| Sep 1999 | - | $14.40 M(+171.7%) |
| Jun 1999 | $5.30 M(-46.5%) | $5.30 M(-10.2%) |
| Mar 1999 | - | $5.90 M(-10.6%) |
| Dec 1998 | - | $6.60 M(-15.4%) |
| Sep 1998 | - | $7.80 M(-21.2%) |
| Jun 1998 | $9.90 M(+1.0%) | $9.90 M(+6.5%) |
| Mar 1998 | - | $9.30 M(-6.1%) |
| Dec 1997 | - | $9.90 M(0.0%) |
| Sep 1997 | - | $9.90 M(+1.0%) |
| Jun 1997 | $9.80 M(+8.9%) | $9.80 M(+15.3%) |
| Mar 1997 | - | $8.50 M(-8.6%) |
| Dec 1996 | - | $9.30 M(-4.1%) |
| Sep 1996 | - | $9.70 M(+7.8%) |
| Jun 1996 | $9.00 M | $9.00 M(+2.3%) |
| Mar 1996 | - | $8.80 M(+87.2%) |
| Dec 1995 | - | $4.70 M |
FAQ
- What is Myriad Genetics annual total current liabilities?
- What is the all time high annual current liabilities for Myriad Genetics?
- What is Myriad Genetics annual current liabilities year-on-year change?
- What is Myriad Genetics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Myriad Genetics?
- What is Myriad Genetics quarterly current liabilities year-on-year change?
What is Myriad Genetics annual total current liabilities?
The current annual current liabilities of MYGN is $164.10 M
What is the all time high annual current liabilities for Myriad Genetics?
Myriad Genetics all-time high annual total current liabilities is $217.50 M
What is Myriad Genetics annual current liabilities year-on-year change?
Over the past year, MYGN annual total current liabilities has changed by +$8.20 M (+5.26%)
What is Myriad Genetics quarterly total current liabilities?
The current quarterly current liabilities of MYGN is $164.10 M
What is the all time high quarterly current liabilities for Myriad Genetics?
Myriad Genetics all-time high quarterly total current liabilities is $274.90 M
What is Myriad Genetics quarterly current liabilities year-on-year change?
Over the past year, MYGN quarterly total current liabilities has changed by +$8.20 M (+5.26%)